tral position in explaining the mechanism and site of action of the sulfonamides, the question now arises, Do PAS and the sulfonamides inhibit the same metabolic process?
The ml, but the parent strain did not grow in 10 ,ug of drug per ml. These strains were cultured in concentrations of PAS ranging from 0.1 ,ug to 10 ,ug per ml of medium. The results were read after incubation for 14 days. Both strains were inhibited equally by PAS.
DISCUSSION AND SUMMARY
Although it is known that para-aminobenzoic acid antagonizes the action of both para-aminosalicylic acid and selected sulfonamides, it is our assumption that these drugs act upon different metabolic processes within the bacterial cell since there is no cross resistance between PAS-resistant and sulfonamideresistant organisms. Ivanovics (1950) has reported that a PAS-resistant strain of Mycobacterium tuberculo&si in addition to being sensitive to the action of sulfamethylthiazole, showed a greater sensitivity than the parent strain. In our opinion the suggestion of increased sensitivity of the PAS-resistant strain shown in table 1 may be disregarded since a repeat test showed no appreciable difference between the PAS-resistant and the parent H37Rv strains with regard to sulfonamide sensitivity. Moreover, when the ST-resistant and parent strains were tested against PAS, even in very low concentrations, both were found to be equally sensitive.
The Woods-Fildes' theory claims that sulfonamides specifically block the growth stimulation by or the utilization of PABA. On the other hand, Sevag (1946) proposed that sulfonamides inhibit various oxidative-reductive enzyme systems. Sevag et al. (1942 reported that in in vitro enzyme systems PABA functions as an antagonist to sulfonamides or an analogous inhibitor. It has been shown that sulfonamides inhibit, among other enzymes, flavoproteins. ,pg of drug per ml of medium pg of drug per ml of medium PABA also has been shown to inhibit flavoproteins (Altman, 1946; Hellerman et al., 1946 Since sulfonamides are capable of blocking so many varieties of enzyme systems, it is evident that the antagonistic action of PABA to sulfonamides could not be assumed to be limited to a single specific site. It seems reasonable, therefore, to conclude that PAS and sulfonamides may act on different enzyme systems, the inhibition of which by either drug, as shown, can be antagonized by PABA. These relationships appear to be capable of explaining the ability of PABA to antagonize both PAS and sulfonamides, and also account for the demonstrated absence of cross resistance between these two drugs.
The assumption based on the antagonism exercised by PABA that if resistance develops to one drug of such a series there will also be resistance to the remaining members of the series cannot be supported by the results obtained with PAS and sulfonamides and the observations discussed above.
